Stay Informed

Sign up for news & alerts

Already signed up?
Login here
What Can I Do?


Get Help
Need alcohol or drug help for yourself or someone else? GET HELP
Continuing Education
Free online courses for addiction counselors LEARN ONLINE
Resources
Resources
Find useful publications, online documents & more.


DrugScreening.org


 

SAMHSA Issues Heroin/Fentanyl Alert
June 12, 2006

Share Share Email
Email
Print
Print
SubscribeSubscribe
News Summary

After more than 100 overdose deaths over two months, the federal Substance Abuse and Mental Health Services Administration (SAMHSA) has alerted the addiction treatment community about a deadly combination of heroin and fentanyl, USA Today reported June 9.

"There's starting to be some increased awareness at the higher levels of government," said Robert Lubran, director of SAMHSA's division of pharmacologic therapies.

The U.S. Drug Enforcement Administration (DEA) issued a warning last month about the heroin-fentanyl mix, a potent blend that has been traced to scores of overdoses and deaths in cities from Chicago to Philadelphia to St. Louis.

A recent raid on a drug lab in Mexico was touted as dealing a blow to the source of the fentanyl, and some city officials say that the crisis appears to have peaked. 

COMMENTS ON THIS ARTICLE:

Your Turn! Post a public comment (read guidelines):

Name:

Comment:
(limit 200
words)

Enter this word
(help):
Change

GUIDELINES: 
To keep this feature useful for all, please:

  1. Keep it clean, courteous, and on-topic. Comments are meant for thoughtful discussion of the article published above.

  2. Do not post promotional links to organizations, products or services, or personal requests for assistance (get help).

  3. Proof your comments carefully, use good spelling and punctuation, and don't use ALL CAPS. Comments are published immediately and cannot be edited.

Deceptive, slanderous and commercially-motivated posts are prohibited. We reserve the right to remove comments not conforming to these guidelines. (Report a comment).

Have questions or feedback? Contact us.